A career researcher committed to evidence-based understanding of high impact healthcare problems, Meridith Peratikos leads a team that conducts research studies, methodological oversight, and literature review.
Prior to axialHealthcare, Meridith was a biostatistician and protocol manager for multi-center clinical trials conducted through the American College of Radiology Imaging Network at Brown University. She served full-time as a faculty member in Vanderbilt University Medical Center (VUMC) Department of Biostatistics, where she primarily collaborated within the Vanderbilt Institute for Global Health on observational cohort research in HIV/AIDS. Meridith is currently an Adjunct Instructor in the Department of Biostatistics at VUMC. She holds a bachelor’s degrees in statistics and sociology and a master’s degree in statistics from Case Western Reserve University. Meridith is lead or co-author on nearly 100 peer-reviewed publications (https://scholar.google.com/citations?hl=en&user=Ix2xcSsAAAAJ).
Where's the Evidence? Barriers to Analyzing Digital Health's Impact
While digital health companies strive to address important healthcare issues by developing products and service offerings in various categories such as genome sequencing, analytics, telemedicine, mobile apps, and population health management tools, little evidence is available in the digital space when it comes to peer-reviewed publications, measurement of potential impact, and effect on patients with the greatest burden of disease, says Meridith Peratikos, Director of Enterprise Research, axialHealthcare.